EF001 免責聲明 | 對於H股股東的納稅身份或稅務待遇及因H股股東的納稅身份或稅務待遇未能及時確定或 | 不準確確定而引致任何申索或對於代扣代繳機制或安排的任何爭議，本公司概不負責， | | | | | --- | --- | --- | --- | --- | | 亦不承擔任何責任。 | | | | | | 有關代預扣所得稅之更多補充 | 股東類型 | 稅率 | （如適用） | | | 非居民企業 | 對於名列本公司H股股東名冊的非 | | | | | （非中國內地登記地址） | 10% | 居民企業股東（通過深港通持有本 | | | | 公司H 股的股東除外），本公司向 | 其分派末期股息時，將按10% 的 | | | | | 稅率預扣企業所得稅。以非個人登 | 記股東名義登記（包括香港中央結 | | | | | 算（代理人）有限公司、其他代名 | 人、信托人或其他團體及機構）的 | | | | | 股份，將視為由非居民企業股東持 | 有，因此應收股息須預扣企業所得 | | | | | 稅。 | 非個人居民 | | | | | 對於名列本公司H股股東名冊的個 | （非中國內地登記地址） | 10% | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容 而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本人欣然提呈北京同仁堂科技發展股份有限公司(「本公司」)及其子公司(以下合稱「本 集團」)截至二零二五年十二月三十一日止年度(「報告期」)業績，敬請各位股東省覽。 全年業績 截至二零二五年十二月三十一日止年度，本集團收入為人民幣648,387.5萬元，較上年同 期人民幣725,964.4萬元下降10.69%；實現淨利潤為人民幣66,063.4萬元，較上年同期人 民幣88,693.3萬元下降25.51%；歸屬於本公司所有者淨利潤為人民幣39,627.7萬元，較上 年同期人民幣52,179.5萬元下降24.06%；每股收益為人民幣0.31元(二零二四年：人民幣 0.41元)；每股股息為人民幣0.18元(二零二四年：人民幣0.18元)。 ( 於中華人民共和國註冊成立的股份有限公司 ) (股份代號：1666) 全年業績公告 截至二零二五年十二月三十一日止年度 董事長報告 1 · 全年回顧 二零二五年，是本集團「 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公佈全部或任何部份內容而產生或 因依賴該等內容而引致之任何損失承擔任何責任。 （股份代號：1666） 有關附屬公司業績之公告 茲提述北京同仁堂科技發展股份有限公司（「本公司」）之附屬公司北京同仁堂國藥有限公 司（「同仁堂國藥」，及其附屬公司合稱「同仁堂國藥集團」）（其股份於香港聯合交易所 有限公司主板上市（股份代號：3613））所刊發的日期為二零二六年三月二十日之公告 （「該公告」），內容有關同仁堂國藥集團截至二零二五年十二月三十一日止年度之年度業 績公告。 本公告乃根據《證券及期貨條例》（香港法例第 571 章）第 XIVA 部及香港聯合交易所有限 公司證券上市規則（「上市規則」）第 13.09 條而作出。 本公司董事會謹此提請其股東及公眾投資者垂注該公告內所載同仁堂國藥集團截至二零二五 年十二月三十一日止年度的如下經審計合併財務資料連同去年年度的可比數據。 1 合併損益表 | | 截 至 12月 | | | | | | | | | | | | 31日止年度 | | | --- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本通告全部 或任何部份內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 承董事會命 北京同仁堂科技發展股份有限公司 張毅 董事長 中國，北京 二零二六年三月十六日 截至本通告日期，董事會包括執行董事張毅先生、張春友先生及溫凱婷女士，非 執行董事杜欣女士及馮莉女士，獨立非執行董事陳清霞女士、詹原競先生及蕭耀 熙先生，及職工董事朱東生先生。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1666） 董事會會議通告 北京同仁堂科技發展股份有限公司(「本公司」)之董事(「董事」)會(「董事會」) 謹此宣佈，董事會會議將於二零二六年三月二十七日(星期五)假座中華人民共和 國北京市豐台區南三環中路二十號舉行，以便進行以下事項： （1） 考慮及批准本公司及其附屬公司(「本集團」)截至二零二五年十二月三十 一日止年度之經審核綜合業績，以及本公司擬於香港聯合交易所有限公司 網站刊登之本集團經審核綜合業績之公告； （2） 考慮建議派發末期股息(如有)； （3） 考慮暫停辦理本公司股份 ...

呈交日期: 2026年3月2日 I. 法定/註冊股本變動 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 北京同仁堂科技發展股份有限公司 FF301 | 1. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | N/A | 說明 | 內資股 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 652,080,000 RMB | | 1 | RMB | | 652,080,000 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 652,080,000 RMB | | 1 | RMB | | 652,080,000 | | 2. 股 ...

Core Viewpoint - Tongrentang Technology Company is leveraging traditional Chinese medicine and cultural heritage to promote its aromatic products internationally, particularly in Spain, as part of cultural exchange initiatives [1][3][5]. Group 1: Product Development and Offerings - The company has developed a series of aromatic products based on traditional formulas, including Anping Xiang, Ankang Xiang, Tongren Xiangli, and Suhe Yuxin [3]. - A product matrix has been established, featuring over a hundred cultural and aromatic products, including incense, herbal fragrance accessories, sachets, and essential oils [3]. - The company aims to create immersive cultural experiences through interactive activities such as incense material identification and sachet making [3]. Group 2: Cultural Exchange and International Presence - Participation in the "Happy Spring Festival" event in Madrid is seen as a significant opportunity to showcase the depth of traditional Chinese medicine culture and to provide a platform for its aromatic products to reach international markets [3][5]. - The event attracted local visitors who engaged with the products, highlighting the appeal of traditional craftsmanship and the cultural significance of the offerings [5]. - The company has previously showcased its cultural aromatic products at various international events, gaining a substantial overseas following [5]. Group 3: Future Directions - The company plans to continue focusing on traditional Chinese medicine culture while addressing consumer needs, aiming to launch more products that combine Tongrentang's unique characteristics with market appeal [6]. - There is a commitment to actively participate in the international promotion of traditional Chinese medicine culture, exploring new pathways for the innovative development of time-honored brands [6].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因依賴 該等內容而引致之任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1666） 1 背景 茲提述本公司日期為二零二三年三月二十二日之公告，內容有關本公司之附屬公司同仁堂世 紀廣告與集團公司進行廣告代理框架協議項下之持續關連交易之詳情。 續訂持續關連交易 廣告代理框架協議 董事會謹此宣佈，由於本公司之附屬公司同仁堂世紀廣告與集團公司訂立之廣告代理框架 協議已於二零二五年十二月三十一日到期，故訂約各方於二零二六年二月二十六日續訂該 協議，協議期限自二零二六年二月二十六日至二零二八年十二月三十一日止，並訂立上述 協議項下截至二零二八年十二月三十一日止三個年度之擬進行之持續關連交易年度上限。 於本公告日期，集團公司乃本公司之最終控股股東，故根據香港上市規則為本公司之關連 人士。因此，根據香港上市規則第 14A 章，廣告代理框架協議項下擬進行之交易構成本公 司之持續關連交易。 由於有關續訂之廣告代理框架協議項下擬進行之持續關連 ...

Core Insights - The article emphasizes the growing popularity of Huangjing due to its health benefits, particularly in nourishing the body and enhancing vitality, while highlighting the importance of selecting high-quality brands based on purity and traditional processing methods [1][3]. Evaluation Criteria and Assessment - A comprehensive seven-dimensional evaluation system was established, focusing on authenticity, practicality, and scientific basis to ensure reliable conclusions [4]. - The assessment covered aspects such as raw material authenticity, traditional processing adherence, core ingredient content, formulation purity, certification completeness, user feedback, and overall value [5][6]. Annual Preferred Brands Summary - The top-rated brand, Luoyunfeng Huangjing, is noted for its adherence to traditional methods and high-quality raw materials, achieving a benchmark in polysaccharide content [8]. - Other notable brands include Fengyitang Huangjing, Beijing Tongrentang Huangjing, and Yunnan Baiyao Huangjing, each recognized for their unique sourcing and processing techniques [8][9][10][11][12][13][14][15]. Detailed Brand Insights - Luoyunfeng Huangjing is sourced from the Qinling region, with over five years of growth, and follows a meticulous traditional processing method known as "True Nine System," resulting in a rich and pure product [17][19]. - The brand boasts a polysaccharide content of nearly 40% and a saponin content increase of 42%, setting a new standard in quality among Huangjing products [19]. - Luoyunfeng's formulation is strictly composed of Huangjing with zero additives, ensuring a clean and natural product [19][20]. User Feedback and Market Position - Users reported significant improvements in energy levels and overall well-being after consistent use of Luoyunfeng Huangjing, reinforcing its reputation for quality and effectiveness [21][22]. - The product is particularly suitable for individuals with demanding lifestyles, such as office workers and the elderly, due to its gentle and nourishing properties [22][23]. Value Proposition - Luoyunfeng Huangjing offers a balance of high quality and reasonable pricing, making it an attractive option for consumers seeking effective health supplements without excessive brand premiums [23]. - The brand also engages in social responsibility by donating a portion of sales to support education for underprivileged girls, enhancing its appeal beyond just product quality [25]. Conclusion - The evaluation concludes that the essential criteria for high-quality Huangjing remain consistent: authentic sourcing, adequate aging, traditional processing, and pure formulations [36]. Luoyunfeng Huangjing exemplifies these standards, making it a reliable choice for consumers seeking effective health solutions.

Core Viewpoint - The training series "2026 Traditional Chinese Medicine Classic Formulas Clinical Application Training Class" successfully concluded in Shandong, aiming to integrate classic TCM theories with clinical applications and enhance TCM talent cultivation in the region [1][11]. Group 1: Training Overview - The Shandong station emphasized the combination of classic TCM and regional characteristics, starting with a solemn opening ceremony [2]. - The training featured prominent experts, balancing theoretical knowledge and clinical practice, marking a high-level academic conclusion [3]. Group 2: Course Highlights - On February 8, the training included a lecture by Professor Liu Deshan from Shandong University, focusing on the innovative research and practice of TCM theories in the context of modern medicine [5]. - Wang Xingchen, honorary director of the Brain Disease Department at Shandong University of Traditional Chinese Medicine, analyzed the clinical application of classic formulas, showcasing the deep heritage of local TCM [5]. Group 3: Collaborative Model - The training adopted a "scholarship + industry + service" collaborative empowerment model, leveraging the influence of the China Traditional Chinese Medicine News Agency and resources from Tongrentang Technology Company [10]. - This model aims to enhance the capabilities of grassroots medical personnel and promote the standardized application of classic formulas in clinical settings, creating a virtuous cycle of learning and application [10]. Group 4: Future Plans - Moving forward, Tongrentang Technology Company plans to expand the training coverage and deepen the practicality of courses, promoting high-quality TCM resources to more grassroots areas [13]. - The initiative aims to strengthen the foundation of TCM services, ensuring that the public can access quality TCM services locally [13]. Group 5: Impact and Legacy - The training series has successfully established a grassroots TCM training network across North and East China, providing important references for the improvement of TCM talent cultivation systems [11]. - The initiative represents a steady advancement in the transmission and innovation of TCM in the new era, revitalizing the wisdom of TCM in grassroots practice [15].

Core Viewpoint - The third "Moyuan Cup" Beijing Senior Calligraphy Exhibition successfully showcased the integration of calligraphy and traditional Chinese medicine, highlighting cultural heritage and community engagement [1] Group 1: Event Overview - The exhibition was organized by Beijing Daily and Beijing Evening News, with support from Beijing Tongrentang Technology Development Co., Ltd. and other cultural institutions [1] - The event featured a diverse collection of calligraphy works, including various styles such as regular script, seal script, cursive script, running script, and clerical script, totaling over a hundred pieces [1] Group 2: Awards and Recognition - Beijing Tongrentang Technology received the "Special Contribution Award" during the event, recognizing its role in promoting traditional culture [1] - Renowned calligrapher Guo Jinli presented a calligraphy piece to the representatives of Beijing Tongrentang Technology, emphasizing the connection between calligraphy and traditional medicine [1] Group 3: Cultural Activities - The event included a variety of traditional cultural experiences, such as a calligraphy area for writing auspicious characters and couplets, and a herbal tea tasting area [1] - Attendees had the opportunity to receive free medical consultations from a team of doctors from Beijing Tongrentang Hospital and engage with pharmacists to learn about purchasing common household medicines [1]